News & Updates

Botulinum toxin-A beneficial to children with treatment-resistant dysfunctional voiding

13 Nov 2023

In children with treatment-resistant dysfunctional voiding, the use of botulinum toxin-A (BTX-A) helps with postvoid residuals (PVR), urinary tract infections (UTIs), and incontinence, according to a study.

Botulinum toxin-A beneficial to children with treatment-resistant dysfunctional voiding

13 Nov 2023

Multimodal intervention reduces second-line antibiotic prescriptions for UTI

13 Nov 2023 by

A multimodal intervention applied in general practice results in a significant decrease in antibiotic prescribing and an increase in guideline adherence among women with uncomplicated urinary tract infection (UTI), a study has shown.

Multimodal intervention reduces second-line antibiotic prescriptions for UTI

13 Nov 2023

Melatonin helps improve pulmonary rehabilitation outcomes in COPD

13 Nov 2023

For patients with chronic obstructive pulmonary disease (COPD) who are undergoing pulmonary rehabilitation, melatonin supplementation leads to improvements in functional capacity, health status, and quality of life, as shown in a study.

Melatonin helps improve pulmonary rehabilitation outcomes in COPD

13 Nov 2023

JAK inhibitor use tied to increased odds of acne

12 Nov 2023

Exposure to Janus kinase (JAK) inhibitors potentially carries an increased likelihood of developing acne, according to a study.

JAK inhibitor use tied to increased odds of acne

12 Nov 2023

Add-on vancomycin of little help for surgical prophylaxis in arthroplasty

11 Nov 2023

Adding vancomycin to cefazolin does not appear to confer significant benefits for the prevention of surgical site infections following arthroplasty in patients without known methicillin-resistant Staphylococcus aureus (MRSA) colonization, according to the results of the ASAP trial.

Add-on vancomycin of little help for surgical prophylaxis in arthroplasty

11 Nov 2023

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

11 Nov 2023 by

Induction chemotherapy followed by chemoradiotherapy (CRT) significantly improves progression-free survival (PFS) and overall survival (OS) in patients with locally advanced cervical cancer compared with standard CRT alone, according to the INTERLACE trial presented at ESMO 2023.

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

11 Nov 2023

Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer

10 Nov 2023 by

Treatment with pyrotinib in combination with trastuzumab and docetaxel (tras/doc) results in longer progression-free survival (PFS) than placebo combined with tras/doc in patients with untreated HER2-positive metastatic breast cancer, a study has shown. In addition, the safely profile of tras/doc plus pyrotinib is manageable.

Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer

10 Nov 2023

Datopotamab deruxtecan shows PFS benefit in patients with HR+/HER2- breast cancer

10 Nov 2023 by

Treatment with datopotamab deruxtecan (Dato-DXd), an investigational TROP2*-directed antibody-drug conjugate, significantly improves progression-free survival (PFS) in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer, according to the TROPION-Breast01 trial presented at ESMO 2023.

Datopotamab deruxtecan shows PFS benefit in patients with HR+/HER2- breast cancer

10 Nov 2023

Simvastatin not superior to standard of care critically ill patients with COVID-19

09 Nov 2023

In the treatment of critically ill patients with COVID-19, simvastatin is not necessarily better than standard of care in terms of improving organ support-free days and death outcomes, according to a study.

Simvastatin not superior to standard of care critically ill patients with COVID-19

09 Nov 2023

LIPI score predicts survival in NSCLC patients treated with PD-1/PD-L1 inhibitor plus chemo

08 Nov 2023

Use of the lung immune prognostic index (LIPI) score can help predict the efficacy of combination therapy of programmed cell death (PD)-1/PD-ligand 1 (PD-L1) blockade and chemotherapy (CT) in patients with advanced nonsmall cell lung cancer (NSCLC), suggests a study.

LIPI score predicts survival in NSCLC patients treated with PD-1/PD-L1 inhibitor plus chemo

08 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Botulinum toxin-A beneficial to children with treatment-resistant dysfunctional voiding

Botulinum toxin-A beneficial to children with treatment-resistant dysfunctional voiding

Multimodal intervention reduces second-line antibiotic prescriptions for UTI

Multimodal intervention reduces second-line antibiotic prescriptions for UTI

Melatonin helps improve pulmonary rehabilitation outcomes in COPD

Melatonin helps improve pulmonary rehabilitation outcomes in COPD

JAK inhibitor use tied to increased odds of acne

JAK inhibitor use tied to increased odds of acne

Add-on vancomycin of little help for surgical prophylaxis in arthroplasty

Add-on vancomycin of little help for surgical prophylaxis in arthroplasty

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

Induction chemotherapy before CRT ups survival in locally advanced cervical cancer

Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer

Pyrotinib plus trastuzumab-docetaxel prolongs PFS in breast cancer

Datopotamab deruxtecan shows PFS benefit in patients with HR+/HER2- breast cancer

Datopotamab deruxtecan shows PFS benefit in patients with HR+/HER2- breast cancer

Simvastatin not superior to standard of care critically ill patients with COVID-19

Simvastatin not superior to standard of care critically ill patients with COVID-19

LIPI score predicts survival in NSCLC patients treated with PD-1/PD-L1 inhibitor plus chemo

LIPI score predicts survival in NSCLC patients treated with PD-1/PD-L1 inhibitor plus chemo